-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Part 2: Prevention and Control of Rheumatic Heart Disease in Kenya: Progress is on the horizon in Work In Progress
- Exploring a Culture of Health: Nurses Making Things with their Hands to Improve Healthcare with MakerNurse in Work In Progress
- A Step-by-Step Approach to Content Management in Work In Progress
- Unpredictable and Magical: The Allure of the Dragonfly Swarm [GUEST POST] in Work In Progress
- Introducing a New Look for the Journal Homepages in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Industry’s Influence
Category: Drug Development, Housekeeping, Industry funding
Tagged Aaron Kesselheim, bondaglutaraz, clinical trials, drug development, Jeffrey Drazen, New England Journal of Medicine, NIH, pharmaceutical industry
Comments Off
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.